Amide 11 decreased MycN levels concomitantly with a decrease of CRABP-II in neuroblastoma IMR-32 cells, whereas 11 hardly inhibited proliferation of HT1080 and MCF-7 cells, which express CRABP-II and cIAP1, but not MycN. This evidence concerns the gene MYCN and neuroblastoma.